Medication info
Laro Duo Tablet

Laro Duo Tablet

Prescription medicationTabletOral
Ingredient · strength
Raloxifene Hydrochloride›45mg / 1 tabletCholecalciferol Concentrate Powder›8mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
Yellow, biconvex, round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202104944 · Approved 2021.06.29 · Insurance code 645405970

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women
Who takes it
Adults
Adult dose
Administer 1 tablet orally once daily.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

This medication is used to treat and prevent osteoporosis which is likely to develop in postmenopausal women.

How to take

Adult dose

Administer 1 tablet orally once daily.

Precautions

This medication may increase the risk of blood clots in the bloodstream, so caution is required for patients at high risk of thrombosis. Especially if immobilization occurs, treatment with this medication should be discontinued and may be resumed once symptoms improve. As this medication is primarily metabolized in the liver, patients with impaired liver function should avoid its use or be carefully monitored. It is not recommended for use in premenopausal women, and women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. It is not used for the prevention of cardiovascular diseases, and caution is needed for patients with a history of stroke or at high risk of stroke. If any abnormal symptoms such as breast or uterine bleeding occur while taking this medication, consult a doctor immediately. Common symptoms that may appear include facial flushing due to vasodilation, leg cramps, cold symptoms, and peripheral edema, so symptoms should be carefully monitored. Moreover, this medication should not be administered to patients with certain genetic issues or hypercalcemia and those with kidney stones. There may be interactions when used with other drugs, so inform healthcare providers of any medications being taken. In case of overdose, symptoms such as dizziness, vomiting, and muscle cramps may occur, so dosage must be strictly adhered to. Safety and efficacy have not been established for children, so it is not used in this population. This medication should be stored out of reach of children and it is advisable not to transfer it to other containers.

Side effects

Venous thromboembolism, vascular dilation (flushing), central venous thrombosis, pulmonary embolism, retinal vein thrombosis, superficial venous thrombophlebitis, leg cramps, cold symptoms, peripheral edema, decreased platelet count, elevated AST and ALT, cholelithiasis, thrombocytopenia, nausea, vomiting, abdominal pain, dyspepsia, increased blood pressure, migraine, headache, rash, breast symptoms (pain, swelling, tenderness), arterial thromboembolism, retinal vein occlusion, stroke, death related to central venous thromboembolism, abnormal uterine bleeding, facial swelling, heartburn, constipation, itching, palpitations, fever, weakness, sweating, myalgia, insomnia, perineal pain, weight gain, arthritis, rheumatism-like symptoms, pain, fatigue, tightness, chest discomfort, skin lesions, anxiety, weight loss, seizures, dyspnea, visual disturbances, taste disturbances, psychological symptoms, consciousness disorders, appetite loss, increased thirst, arrhythmia, increased urinary urgency, kidney stones, renal calcification, calcification of peripheral bone tissue, myalgia, arthralgia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius room temperature. This will help you safely maintain the medication's effectiveness.

Appearance and packaging

Appearance

Yellow, biconvex, round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.